The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible
Abstract
Diseases such as multiple sclerosis and Guillain-Barré syndrome are characterized not only by widespread loss of myelin from nerve fibres, but also by widespread inflammation in the central and peripheral nervous systems, respectively. While the demyelination alone is sufficient to block conduction and thereby cause symptoms, there is increasing evidence that the inflammation may also contribute significantly to the conduction block, although the mechanisms are not understood. Nitric oxide is an important inflammatory mediator which is elevated within the central nervous system in multiple sclerosis and which can be experimentally applied to tissues using nitric oxide donors. We report that such compounds cause reversible conduction block in both normal and demyelinated axons of the central and peripheral nervous systems. Notably, conduction in demyelinated and early remyelinated axons is particularly sensitive to block by nitric oxide, so that at lower concentrations, including those expected at sites of inflammation, demyelinated axons are selectively affected. We therefore propose that inflammation may directly cause symptoms via nitric oxide release, and that the inhibition of such release may open a new therapeutic avenue for demyelinating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
Bredt, D. S., & Snyder, S. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.9030 · Cited by 1,840
Nitric Oxide Signaling in the Central Nervous System
Garthwaite, J., & Boulton, C. L. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003343 · Cited by 1,638
Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum
Shibuki, K., & Okada, D. (1991) · Nature · doi:10.1038/349326a0 · Cited by 871
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2132 · Cited by 781
Malinski, T., Bailey, F., Zhang, Z. G., & Chopp, M. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.48 · Cited by 625
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S., Möurk, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.
Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., & Dietzschold, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.3024 · Cited by 474
Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12041 · Cited by 456
Nitric Oxide‐Mediated Inhibition of the Mitochondrial Respiratory Chain in Cultured Astrocytes
Bolaños, J. P., Peuchen, S., Heales, S. J. R., Land, J. M., & Clark, J. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030910.x · Cited by 415
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117282 · Cited by 384
THE EFFECTS OF EXPERIMENTAL DEMYELINATION ON CONDUCTION IN THE CENTRAL NERVOUS SYSTEM
MCDONALD, W. I., & SEARS, T. A. (1970) · Brain · doi:10.1093/brain/93.3.583 · Cited by 373
Cyclic Nucleotide-Gated Ion Channels: An Extended Family With Diverse Functions
Finn, J. T., Grunwald, M. E., & Yau, K.-W. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.002143 · Cited by 326
LIZASOAIN, I., MORO, M. A., KNOWLES, R. G., DARLEY-USMAR, V., & MONCADA, S. (1996) · Biochemical Journal · doi:10.1042/bj3140877 · Cited by 318
Butler, A. R., Flitney, F. W., & Williams, D. L. H. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88968-3 · Cited by 302
Mitrovic, B., Ignarro, L. J., Montestruque, S., Smoll, A., & Merrill, J. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90435-9 · Cited by 259
YOUL, B. D., TURANO, G., MILLER, D. H., TOWELL, A. D., MACMANUS, D. G., MOORE, S. G., JONES, S. J., BARRETT, G., KENDALL, B. E., MOSELEY, I. F., et al. (1991) · Brain · doi:10.1093/brain/114.6.2437 · Cited by 259
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
Moreau, T., Coles, A., Wing, M., Isaacs, J., Hale, G., Waldmann, H., & Compston, A. (1996) · Brain · doi:10.1093/brain/119.1.225 · Cited by 250
Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies.
Lampert, P. W. (1969) · PubMed · Cited by 223
Reactive Nitrogen Intermediates in Human Neuropathology: An Overview
Brosnan, C. F., Battistini, L., Raine, C. S., Dickson, D. W., Casadevall, A., & Lee, S. C. (1994) · Developmental Neuroscience · doi:10.1159/000112102 · Cited by 209
Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration
Brown, G. C., Bolaños, J. P., Heales, S. J. R., & Clark, J. B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11703-y · Cited by 204
Hall, S. M., & Gregson, N. A. (1971) · Journal of Cell Science · doi:10.1242/jcs.9.3.769 · Cited by 195
Local nitric oxide production in viral and autoimmune diseases of the central nervous system.
Hooper, D. C., Ohnishi, S. T., Kean, R., Numagami, Y., Dietzschold, B., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5312 · Cited by 184
THE RESTORATION OF CONDUCTION BY CENTRAL REMYELINATION
SMITH, K. J., BLAKEMORE, W. F., & MCDONALD, W. I. (1981) · Brain · doi:10.1093/brain/104.2.383 · Cited by 183
Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T., & Sakoda, S. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00114-h · Cited by 176
ETHIDIUM BROMIDE INDUCED DEMYELINATION IN THE SPINAL CORD OF THE CAT
BLAKEMORE, W. F. (1982) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1982.tb00305.x · Cited by 170
Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ
Goodwin, J. L., Uemura, E., & Cunnick, J. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00646-8 · Cited by 165
Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin
Blakemore, W. F., Eames, R. A., Smith, K. J., & McDonald, W. I. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90179-4 · Cited by 161
Zhao, W., Tilton, R. G., Corbett, J. A., McDaniel, M. L., Misko, T. P., Williamson, Cross, A. H., & Hickey, W. F. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00158-1 · Cited by 157
Conduction properties of central nerve fibers remyelinated by Schwann cells
Felts, P. A., & Smith, K. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90815-q · Cited by 141
Zielasek, J., Jung, S., Gold, R., Liew, F. Y., Toyka, K. V., & Hartung, H. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00192-q · Cited by 139
Nerve conduction during peripheral demyelination and remyelination
Smith, K. J., & Hall, S. M. (1980) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(80)90201-4 · Cited by 134
Ruuls, S. R., van der Linden, S., Sontrop, K., Huitinga, I., & Dijkstra, C. D. (1996) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1996.tb08304.x · Cited by 123
Evidence for increased nitric oxide production in multiple sclerosis.
Johnson, A. W., Land, J. M., Thompson, E. J., Bolaños, J. P., Clark, J. B., & Heales, S. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.1.107 · Cited by 120
van Dam, A., Bauer, J., Man‐A‐Hing, W. K. H., Marquette, C., Tilders, F. J. H., & BERKENBOSCH, F. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400214 · Cited by 110
Cross, A. H., Keeling, R. M., Goorha, S., San, M., Rodi, C. P., Wyatt, P. S., Manning, P. T., & Misko, T. P. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00147-6 · Cited by 86
Smith, K. J. (1994) · Eye · doi:10.1038/eye.1994.51 · Cited by 62
Nitric oxide-dependent blood-brain barrier permeability alteration in the rat brain
Shukla, A., Dikshit, M., & Srimal, R. C. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01923358 · Cited by 52
Inducible nitric oxide synthase in the central nervous system
Sparrow, J. R. (1994) · Journal of Molecular Neuroscience · doi:10.1007/bf02736723 · Cited by 43
A sensitive method for the detection and quantification of conduction deficits in nerve
Smith, K. J. (1980) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(80)90200-2 · Cited by 37
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Mitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Metadata
- Authors
- Redford, E.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 2149-2157
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2123444403
- Cited by
- 326
- References
- 39
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.